Phytochemical screening and anticonvulsant property of Ocimum basilicum leaf essential oil

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas

Volumn 8, Issue 3, 2009, Pages 195-202

  Oliveira, Juliana S ^a   Porto, Lívia A ^a   Estevam, Charles S ^a   Siqueira, Rosana S ^a   Alves, Péricles B ^a   Niculau, Edenilson S ^a   Blank, Arie F ^a   Almeida, Reinaldo N ^b   Marchioro, Murilo ^a   Quintans Jr , Lucindo J ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b Universidade Federal da Paraíba LTF UFPB   (Brazil)

Author keywords

Anticonvulsant; CNS depressant; Ocimum basilicum; Pentylenetetrazole; Picrotoxin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CINEOLE; ESSENTIAL OIL; FLUMAZENIL; GERANIOL; LINALOOL; OCIMUM BASILICUM EXTRACT; PENTETRAZOLE; PICROTOXIN; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; ATAXIA; BASIL; CONTROLLED STUDY; CONVULSION; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG INDICATION; DRUG MECHANISM; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PTOSIS; SEDATION; SLEEP TIME;

LAMIACEAE; OCIMUM BASILICUM; STRYCHNOS TOXIFERA;

EID: 77749345731     PISSN: None     EISSN: 07177917     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. th Edition. Illinois USA: Allured Publishing Corporation, Carol Stream, Ill, p. 804.
2. Akerele O. 1988. Medicinal plants and primary health care: an agenda for action. Fitoterapia 59:355-363.
3. Akerele O. 1990. Medicinal plants in traditional medicine, In: Economic and medicinal plants research. Wagner H, and Farnsworth N. (Eds.), Academic Press, London, vol. 4. pp 5-16
4. Almeida RN, Barbosa Filho JM, Navarro DS, Quintans-Júnior LJ, Medeiros IA, Falcão AC GM, Duarte JC, Melo-Diniz MFF. 2005. Anorectic and behavioural effects of chronic Cissampelos sympodialis treatment in female and male rats. Phytother Res 19:121 - 124.
5. Blank AF, Souza EM, Arrigoni-Blank MF, Paula JWA, Alves PB. 2008. Maria Bonita, uma cultivar de manjericão tipo linalol. Pes Agr Bras 43(12):1811-1813.
6. Corrêa MP. 1984. Dicionário das plantas úteis do Brasil e das exóticas cultivadas. Imprensa Nacional, Rio de Janeiro, p. 747.
7. De Sousa DP, Oliveira FS, Almeida RN. 2006. Evaluation of the central activity of hydroxydihydrocarvone. Biol Pharm Bull 29:811-812.
8. De Sousa DP, Nóbrega FFF, Claudino FS, Almeida RN, Leite JR, Rita Mattei R. 2007. Pharmacological effects of the monoterpene α,β-epoxy- carvone in mice. Braz J Pharmacog 17:170-175.
9. Deckers CLP, Genton P, Schmidt D. 2003. Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res 53:1-17.
10. Stasi LC, Oliveira GP, Carvalhaes MA, Queiroz Jr M, Tien OS, Kakinami SH, Reis MS. 2002. Medicinal plants popularly used in the Brazilian Tropical Atlantic Forest. Fitoterapia 73:69-91.
11. Elisabetsky E, Coelho-De-Souza GP, Santos MAC, Siqueira IR, Amador TA. 1995. Sedative properties of linalool. Fitoterapia 66:407-414.
12. Elisabetsky E, Brum LF, Souza DO. 1999. Anticonvulsant properties of linalool in glutamate-related seizure models. Phytomedicine 6:107- 113.
13. Grayer RJ, Kite GC, Goldstone FJ, Bryan SE, Paton A, Putievsky E. 1996. Infraspecific taxonomy and essential oil chemotypes in sweet basil, Ocimum basilicum. Phytochemistry 43:1033-1039.
14. Guenther E. 1975. The Essential Oils; Krieger Publishing Company: Malabar, FL; Vol. III.
15. Haruna AK. 2000. Depressant and anticonvulsant properties of the root decoction of Afromosia taxiflora (leguminosae). Phytother Res 14:57-59.
16. Hasegawa Y, Tajima K, Toi N, Sugimura Y. 1997. Characteristic components found in the essential oil of Ocimum basilicum L.. Flav Frag J 12:195-200.
17. Holm Y. 1999. Bioactivity of basil. In: Hiltunen, R., Holm, Y. (Eds.), Basil. The Genus Ocimum. Harwood Academic Publishers, Amsterdam, pp. 113-136.
18. Jeub M, Beck H, Siep E, Rüschenschmidt C, Speckmann EJ, Ebert U, Potschka H, Freichel C, Reissmüller E, Löscher W. 2002. Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats. Neuropharmacol 42:107-116.
19. Lawrence BM. 1988. A further examination of the variation of Ocimum basilicum L. In Flavors and Fragrances: A World Perspective; Lawrence, B. M., Mookherjee, B. D., Willis, B. J., Eds.; Elsevier Science: Amsterdam, The Netherlands, pp. 161-170.
20. Lee SJ, Umano K, Shibamoto T, Lee KG. 2005. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem 91:131-137.
21. Lehmann J, Hutchison A, McPherson SE, Mondadori C, Schmutz M, Sinton CM, Tsai C, Murphy DE, Steel DJ, Williams M, Cheney DL, Wood PL. 1988. CGS 19755, a selective and competitive N-Metil-Daspartate-type excitatory amino acid receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 246: 65-75.
22. Löscher W, Schmidt D. 1988. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 145-181.
23. Löscher W, Schmidt D. 2006. New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 69:183-272
24. Mäkinen SM, Paakkonen KK. 1999. Processing and use of basil in foodstuffs, beverages and in food preparation. In: Hiltunen, R., Holm, Y. (Eds.), Basil. The Genus Ocimum. Harwood Academic Publishers, Amsterdam, pp. 137-152.
25. Malawska B. 2003. Application of pharmacophore models for the design and synthesis of new anticonvulsant drugs. Mini Rev Med Chem 3:341-348.
26. Martins AP, Salgueiro LR, Vila R, Tomi F, Canigueral S, Casanova J, Proença da Cunha A, Adzet T. 1999. Composition of the essentials oils of Ocimum canum, O. gratissimum and O. minimum. Planta Med 65:187-189.
27. 2 a altas pressões. Quim Nova 29(6): 1198-1202.
28. Meldrum BS, Rogawski MA. 2007. Molecular Targets for Antiepileptic Drug Development. Neurotherapeutics: J Am Soc Exp NeuroTher 4: 18-61.
29. Ngo Bum E, Schmutz M, Meyer C, Rakotonirina A, Bopelet M, Portet C, Jeker A, Rakotonirina SV, Olpe HR, Herrling P. 2001. Anticonvulsant properties of the methanolic extract of Cyperus articulatus (Cyperaceae). J Ethnopharmacol 76:145-150.
30. Nicoll RA. 2001. Introduction to the pharmacology of the central nervous system (CNS), in: B.G. Katzung (Ed.), Basic and Clinical Pharmacology, eighth ed., McGraw-Hill, New York, pp. 351-363.
31. Oliveira FA, Almeida RN, Sousa MFV, Barbosa-Filho JM, Diniz SA, Medeiros IA. 2001. Anticonvulsant properties of N-salicyloyltryptamine in mice. Pharmacol Biochem Behav 68:199-202.
32. Pérez de Alejo JL, Miranda R, Rodríguez G. 1996. Actividad antidepresiva y anticonvulsivante del extracto fluido del Ocimum tenuiflorum L. (albahaca morada). Rev Cubana Plant Med 1:8-12.
33. Perucca E. 2005. An introduction to antiepileptic drugs. Epilepsia 46:31-37.
34. Picard F, Bertrand S, Steinlein OK, Bertrand D. 1999. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine. Epilepsia. 40:1189 -1209.
35. Quintans-Júnior LJ, Souza TT, Leite BS, Lessa NMN, Bonjardim LR, Santos MRV, Alves PB, Blank AF, Antoniolli AR. 2008. Phythochemical screening and anticonvulsant activity of Cymbopogon winterianus Jowitt (Poaceae) leaf essential oil in rodents. Phytomedicine 15: 619-624.
36. Quintans-Júnior LJ, Araújo DAM, Leite JR, Almeida RN. 2005. Efeito anticonvulsivante e anestésico do linalol em roedores. Neurobiologia 68:103-104.
37. Re L, Barocci S, Sonnino S, Mencarelli A, Vivani C, Paolucci G, Scarpantonio A, Rinaldi L, Mosca E. 2000. Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res 42(2):177-181.
38. A receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur J Pharmacol 516:131-138.
39. Silva Brum LF, Emanuelli T, Souza DO, Elisabetisky E. 2001. Effects of linalool on glutamate release and uptake in mouse cortical synaptosomes. Neurochem Res 26:191-194.
40. Suppakul P, Miltz J, Soneveld K, Bigger S. 2003. Antimicrobial Properties of Basil and Its Possible Application in Food Packaging. J. Agric. Food Chem 51:3197-3207.
41. Van Den Dool H. Kratz PD. 1963. A generalization of the retention index system including linear temperature programmed gas - liquid partition chromatography. J Chromatography A 11:463-471.
42. Vieira RF, Grayer RJ, Paton A, Simon JE. 2001. Genetic diversity of Ocimum gratissimum L. based on volatile oil constituents, flavonoids and RAPD markers. Biochem System Ecol 29:287-304.
43. Webb TI, Lynch JW. 2007. Molecular pharmacology of the glycine receptor chloride channel. Curr Pharm Des 13(23):2350-2367.
44. Zhang JW, Li SK, Wu WJ. 2009. The main chemical composition and in vitro antifungal activity of the essential oils of Ocimum basilicum Linn. var. pilosum (Willd.) Benth. Molecules 14(1): 273-278.
45. Zwanzger P, Rupprecht R. 2005. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. J Psychiatry Neurosci 30:167-175.